(Q24675781)
Statements
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation (English)
0 references
February 2007
0 references
81
0 references
3
0 references
1502-5
0 references